Skip to main content

Published locations for Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL

User login

  • Reset your password
  • /content/final-ascend-study-data-acalabrutinib-beat-standard-care-r/r-cll
  • /fedprac/article/230556/cll/final-ascend-study-data-acalabrutinib-beat-standard-care-r/r-cll
  • /hematologynews/article/230556/cll/final-ascend-study-data-acalabrutinib-beat-standard-care-r/r-cll
  • /oncologypractice/article/230556/cll/final-ascend-study-data-acalabrutinib-beat-standard-care-r/r-cll
  • /fedprac/avaho/article/230556/cll/final-ascend-study-data-acalabrutinib-beat-standard-care-r/r-cll
  • /hematology-oncology/article/230556/cll/final-ascend-study-data-acalabrutinib-beat-standard-care-r/r
  • /b-cell-lymphoma-icymi/article/230556/cll/final-ascend-study-data-acalabrutinib-beat-standard-care-r